glp 1 agonists alzheimer's GLP-1R protect against disease by rewiring energy regulation Advances in Clinical and Experimental
Description
We discuss adverse events of specific interest observed with these therapies (and their potential underlying mechanisms), including GI side effects, psychiatric, ocular, thyroid, biliary, and pancreatic complications (Table 1)
A similar increased risk for heart failure was also observed for alogliptin (3.9% vs 3.3% for placebo)
Liraglutide attenuates hepatic ischemia-reperfusion injury by modulating macrophage polarization
Does Costco have the Wegovy pill
J Hepatol 62(1):S47S64
